{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:33Z","timestamp":1753891953225,"version":"3.41.2"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:title>Background:<\/jats:title><jats:p>Statins can cause muscle symptoms resulting in poor adherence to therapy and increased cardiovascular risk. We hypothesize that combinations of potentially functional SNPs (pfSNPs), rather than individual SNPs, better predict myalgia in patients on atorvastatin. This study assesses the value of potentially functional single nucleotide polymorphisms (pfSNPs) and employs six machine learning algorithms to identify the combination of SNPs that best predict myalgia.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Whole genome sequencing of 183 Chinese, Malay and Indian patients from Singapore was conducted to identify genetic variants associated with atorvastatin induced myalgia. To adjust for confounding factors, demographic and clinical characteristics were also examined for their association with myalgia. The top factor, sex, was then used as a covariate in the whole genome association analyses. Variants that were highly associated with myalgia from this and previous studies were extracted, assessed for potential functionality (pfSNPs) and incorporated into six machine learning models. Predictive performance of a combination of different models and inputs were compared using the average cross validation area under ROC curve (AUC). The minimum combination of SNPs to achieve maximum sensitivity and specificity as determined by AUC, that predict atorvastatin-induced myalgia in most, if not all the six machine learning models was determined.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Through whole genome association analyses using sex as a covariate, a larger proportion of pfSNPs compared to non-pf SNPs were found to be highly associated with myalgia. Although none of the individual SNPs achieved genome wide significance in univariate analyses, machine learning models identified a combination of 15 SNPs that predict myalgia with good predictive performance (AUC &amp;gt;0.9). SNPs within genes identified in this study significantly outperformed SNPs within genes previously reported to be associated with myalgia. pfSNPs were found to be more robust in predicting myalgia, outperforming non-pf SNPs in the majority of machine learning models tested.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Combinations of pfSNPs that were consistently identified by different machine learning models to have high predictive performance have good potential to be clinically useful for predicting atorvastatin-induced myalgia once validated against an independent cohort of patients.<\/jats:p>","DOI":"10.3389\/fphar.2021.605764","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T10:51:33Z","timestamp":1619088693000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Robust Performance of Potentially Functional SNPs in Machine Learning Models for the Prediction of Atorvastatin-Induced Myalgia"],"prefix":"10.3389","volume":"12","author":[{"given":"Brandon N. S.","family":"Ooi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Raechell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel F.","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Zher","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherman W. L.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin H. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel S.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack W. C.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester L.","family":"Drum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/clpt.2014.121","article-title":"Phenotype standardization for statin-induced myotoxicity","volume":"96","author":"Alfirevic","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/cpt.1482","article-title":"Pharmacogenomics\u2010driven prediction of antidepressant treatment outcomes: a machine\u2010learning approach with multi\u2010trial replication","volume":"106","author":"Athreya","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0224089","DOI":"10.1371\/journal.pone.0224089","article-title":"Architecture of population-differentiated polymorphisms in the human genome","volume":"14","author":"Bachtiar","year":"","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41397-019-0096-y","article-title":"Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms","volume":"19","author":"Bachtiar","year":"","journal-title":"Pharmacogenomics J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cpt.887","article-title":"Genetic and clinical factors are associated with statin-related myotoxicity of moderate severity: a case-control study","volume":"104","author":"Bakar","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/cvr\/cvy119","article-title":"Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence","volume":"114","author":"Brunham","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/bio.2015.0032","article-title":"A novel approach to high-quality postmortem tissue procurement: the GTEx project","volume":"13","author":"Carithers","year":"2015","journal-title":"Biopreservation and Biobanking"},{"key":"B9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/clpt.2013.161","article-title":"SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink","volume":"94","author":"Carr","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"GigaSci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists","year":"2012","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur. Heart J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen","year":"2012","journal-title":"J. Clin. Lipidol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14375","DOI":"10.1038\/srep14375","article-title":"Dissecting the genetic structure and admixture of four geographical Malay populations","volume":"5","author":"Deng","year":"2015","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/clpt.2010.255","article-title":"Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study","volume":"89","author":"Donnelly","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ejhg.2015.269","article-title":"The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants","volume":"24","author":"Fadista","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature13629","article-title":"GATM locus does not replicate in rhabdomyolysis study","volume":"513","author":"Floyd","year":"2014","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0218115","DOI":"10.1371\/journal.pone.0218115","article-title":"Pharmacogenomics of statin-related myopathy: meta-analysis of rare variants from whole-exome sequencing","volume":"14","author":"Floyd","year":"2019","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/FPC.0b013e328012d0a9","article-title":"CYP2D6*4 polymorphism is associated with statin-induced muscle effects","volume":"17","author":"Frudakis","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16444","DOI":"10.1038\/s41598-018-34753-5","article-title":"Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy","volume":"8","author":"Huang","year":"2018","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.12659\/MSM.893007","article-title":"SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia\/myopathy in a Czech population","volume":"21","author":"Hub\u00e1\u010dek","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/jech.44.1.24","article-title":"Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality","volume":"44","author":"Hughes","year":"1990","journal-title":"J. Epidemiol. Community Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/hmg\/ddx043","article-title":"Conditional eQTL analysis reveals allelic heterogeneity of gene expression","volume":"26","author":"Jansen","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models inRUsing thecaretPackage","volume":"28","author":"Kuhn","year":"2008","journal-title":"J. Stat. Soft."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2013a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0135784","DOI":"10.1371\/journal.pone.0135784","article-title":"Comparison of nine statistical model based warfarin pharmacogenetic dosing algorithms using the racially diverse international warfarin pharmacogenetic consortium cohort database","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.cmet.2015.03.003","article-title":"GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals","volume":"21","author":"Luzum","year":"2015","journal-title":"Cel Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nature12508","article-title":"A statin-dependent QTL for GATM expression is associated with statin-induced myopathy","volume":"502","author":"Mangravite","year":"2013","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/tpj.2015.47","article-title":"Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traits","volume":"16","author":"Maranville","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1345\/aph.1K209","article-title":"Factors related to adherence to statin therapy","volume":"41","author":"McGinnis","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1172\/JCI123462","article-title":"RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity","volume":"129","author":"Mukohda","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/humu.23146","article-title":"Whole-genome sequencing of cytogenetically balanced chromosome translocations identifies potentially pathological gene disruptions and highlights the importance of microhomology in the mechanism of formation","volume":"38","author":"Nilsson","year":"2017","journal-title":"Hum. Mutat."},{"key":"B36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0195-668x(02)00611-5","article-title":"Singapore and coronary heart disease: a population laboratory to explore ethnic variations in the epidemiologic transition","volume":"24","author":"Ounpuu","year":"2003","journal-title":"Eur. Heart J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/01.fpc.0000230416.82349.90","article-title":"SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid","volume":"16","author":"Pasanen","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0378-1119(02)00980-0","article-title":"Genomic organization and expression profile of the small GTPases of the RhoBTB family in human and mouse","volume":"298","author":"Ramos","year":"2002","journal-title":"Gene"},{"key":"B39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/mus.20871","article-title":"Physiogenomic association of statin-related myalgia to serotonin receptors","volume":"36","author":"Rua\u00f1o","year":"2007","journal-title":"Muscle Nerve"},{"key":"B40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.atherosclerosis.2011.07.007","article-title":"Mechanisms of statin-induced myalgia assessed by physiogenomic associations","volume":"218","author":"Rua\u00f1o","year":"2011","journal-title":"Atherosclerosis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.dmpk.2016.09.002","article-title":"A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients","volume":"31","author":"Sai","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pcad.2016.07.009","article-title":"Statin intolerance: a literature review and management strategies","volume":"59","author":"Saxon","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","author":"Armitage","year":"2010","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5114\/amsad.2017.70597","article-title":"Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease","volume":"2","author":"Shek","year":"2017","journal-title":"amsad"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1093\/eurheartj\/ehx467","article-title":"A common missense variant of LILRB5 is associated with statin intolerance and myalgia","volume":"38","author":"Siddiqui","year":"2017","journal-title":"Eur. Heart J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/gepi.21731","article-title":"A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium","volume":"37","author":"Tang","year":"2013","journal-title":"Genet. Epidemiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jbspin.2019.01.018","article-title":"Statins, myalgia, and rhabdomyolysis","volume":"87","author":"Tournadre","year":"2020","journal-title":"Jt. Bone Spine"},{"key":"B50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/jcm9010022","article-title":"Statin-related myotoxicity: a comprehensive review of pharmacokinetic, pharmacogenomic and muscle components","volume":"9","author":"Turner","year":"2019","journal-title":"Jcm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.jacc.2009.04.053","article-title":"The SLCO1B1*5Genetic variant is associated with statin-induced side effects","volume":"54","author":"Voora","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"447367","DOI":"10.1101\/447367","article-title":"Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis","author":"V\u00f5sa","year":"2018","journal-title":"bioRxiv"},{"key":"B53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/humu.21331","article-title":"pfSNP: an integrated potentially functional SNP resource that facilitates hypotheses generation through knowledge syntheses","volume":"32","author":"Wang","year":"2011","journal-title":"Hum. Mutat."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","article-title":"Statin toxicity","volume":"124","author":"Ward","year":"2019","journal-title":"Circ. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jacl.2013.03.001","article-title":"Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education","volume":"7","author":"Wei","year":"2013","journal-title":"J. Clin. Lipidol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4049\/jimmunol.167.1.277","article-title":"The sushi domain of soluble IL-15 receptor \u03b1 is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo","volume":"167","author":"Wei","year":"2001","journal-title":"J. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/clpt.2012.57","article-title":"The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy","volume":"92","author":"Wilke","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"B59","unstructured":"2020"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1038\/emm.2017.150","article-title":"miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1","volume":"49","author":"Xiao","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2174\/1381612825666190705204614","article-title":"Association of SLCO1B1 and ABCB1 genetic variants with atorvastatin-induced myopathy in patients with acute ischemic stroke","volume":"25","author":"Zhang","year":"2019","journal-title":"Cpd"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e22408","DOI":"10.1002\/jcla.22408","article-title":"Analysis of SLCO1B1 and APOE genetic polymorphisms in a large ethnic Hakka population in southern China","volume":"32","author":"Zhong","year":"2018","journal-title":"J. Clin. Lab. Anal."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.605764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T10:51:48Z","timestamp":1619088708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.605764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":62,"alternative-id":["10.3389\/fphar.2021.605764"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.605764","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2021,4,22]]},"article-number":"605764"}}